Sponsored By:

Get Into Express Scripts in a Hurry

WAG deal means good things for the pharmacy benefit manager


Express Scripts (NASDAQ:ESRX) – This company provides healthcare management and administration services for HMOs, health insurers and various compensation plans and systems. Yesterday it ended an extended dispute with Walgreens (NYSE:WAG) over rates and returns. Analysts now project that both companies will benefit, but several analysts reaffirmed their earnings target of $4.60 for 2013 vs. $3.66 this year with a price target of $66.

ESRX broke from a double top at just above $58 yesterday following the crossing of the 20-day moving average through the 50-day moving average last week. The trading target from the breakout is $66. Investors may buy ESRX as a quality long-term hold in the health care management industry.

ESRX Get Into Express Scripts in a Hurry

chart key Get Into Express Scripts in a Hurry

Article printed from InvestorPlace Media, http://investorplace.com/2012/07/get-into-express-scripts-in-a-hurry/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.